Agranulocytosis associated with dipyrone (metamizol)

European Journal of Clinical Pharmacology

Volumn 60, Issue 11, 2005, Pages 821-829

  Ibáñez, Luisa ^a   Vidal, Xavier ^a   Ballarín, Elena ^a   Laporte, Joan Ramon ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRONE; DIPYRONE MAGNESIUM; SCOPOLAMINE BUTYL BROMIDE;

AGRANULOCYTOSIS; ARTICLE; BLOOD DYSCRASIA; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EXPOSURE; DRUG SURVEILLANCE PROGRAM; FOLLOW UP; HOSPITAL LABORATORY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PATIENT INFORMATION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; STATISTICAL ANALYSIS;

EID: 15444365892     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0836-y     Document Type: Article

References (28)

1. Kaufman DW, Kelly JP, Levy M, Shapiro S (1991) The drug etiology of agranulocytosis and aplastic anemia. Oxford University Press, New York
2. Kaufman DW, Kelly JP, Levy M, Shapiro S (1986) The drug etiology of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 256:1749-1757
3. van der Klauw MM, Goudsmit R, Halie MR, van't Veer MB, Herings RMC, Wilson JHP, Stricker BHCh (1999) A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med 159:369-374
4. Maj S, Lis Y (2002) The incidence of metamizol sodium-induced agranulocytosis in Poland. J Int Med Res 30:488-495
5. Hedenmalm K, Spigset O (2002) Agranulocytosis and other blood dyscrasias associated with metamizol (metamizol). Eur J Clin Pharmacol 58:265-274
6. Ibáñez L, Juan J, Pérez E, Carné X, Laporte J-R (1991) Agranulocytosis associated with aprindine and other antiarrhythmic drugs: an epidemiological approach. Eur Heart J 12:639-641
7. Laporte JR, Capellà D, Juan J (1990) Agranulocytosis induced by cinepazide. Eur J Clin Pharmacol 38:387-388
8. Ibáñez L, Ballarín E, Pérez E, Vidal X, Capellà D, Laporte JR (2000) Agranulocytosis induced by pyrithyldione, a sedative hypnotic drug. Eur J Clin Pharmacol 55:761-764
9. Ibáñez L, Ballarín E, Vidal X, Laporte JR (2000) Agranulocytosis associated with calcium dobesilate. Clinical course and risk estimation with the case-control and the case-population approaches. Eur J Clin Pharmacol 56:763-767
10. International Agranulocytosis and Aplastic Anemia Study (1983) The design of a study of the drug etiology of agranulocytosis and aplastic anemia. Eur J Clin Pharmacol 24:833-836
11. Discombe G (1952) Agranulocytosis caused by amidopyrine: an avoidable cause of death. BMJ i:1270-1273
12. Huguley CM (1964) Agranulocytosis induced by dipyrone, a hazardous antipyretic and analgesic. JAMA 189:938-941
13. Palva IP, Mustala DO (1970) Drug induced agranulocytosis with special reference to aminophenazone. Acta Med Scand 187:109-115
14. Böttiger LE, Westerholm B (1973) Drug-induced blood dyscrasias in Sweden. BMJ iii:339-343
15. Varonos DD, Santamouris S, Karambali S (1979) The incidence of dipyrone induced agranulocytosis in Greece during 1975. J Int Med Res 7:564-568
16. Laporte JR, Carné X (1987) Blood dyscrasias and the relative safety of non-narcotic analgesics. Lancet i:809
17. Bäckstrom M, Hägg S, Mjörndal T, Dahlqvist R (2002) Utilization pattern of metamizol in northern Sweden and risk estimates of agranulocytosis. Pharmacoepidemiol Drug Saf 11:239-245
18. Capellà D, Laporte JR, Vidal X, Wiholm B-E, Bégaud B, Langman MJS, Rawlins M (1999) European network for the case-population surveillance of rare diseases (Euronet). A prospective feasibility study. Eur J Clin Pharmacol 53:299-302
19. Coordinating Centre (1999) A feasibility study of a European case-cohort surveillance network (EURONET) of serious ADRs to new pharmaceutical products. Euronet: final report. Contract no BMH4-CT95-0467 (DG 12 - SSMA). DG XII, European Commission, Brussels
20. Herxheimer A, Yudkin JS (1984) Agranulocytosis and pyrazolone analgesics. Lancet i:730
21. Shapiro S (1984) Agranulocytosis and pyrazolone. Lancet i:1471.
22. Laporte J-R, Ibáñez L, Vidal X, Vendrell L, Leone R (2004) Upper gastrointestinal bleeding associated with the use of NSAIDs. Newer versus older agents. Drug Saf 27:411-420
23. Ibáñez L, Pérez E, Vidal X, Laporte J-R, The Grup d'Estudi Multicèntric d'Hepatotoxicitat Aguda de Barcelona (GEMHAB) (2002) Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs. J Hepatol 37:592-600
24. Böttiger LE, Westerholm B (1973) Acquired hemolytic anaemia. I. Incidence and aetiology. Acta Med Scand 193:223-226
25. Van der Klauw MM, Stricker B-HCh, Herings RMC, Cost WS, Valkenburg HA, Wilson JH (1993) A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 35:400-408
26. Roujeau J-C, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, Mockenhaupt M, Paoletti C, Shapiro S, Shear N, Schöpf E, Kaufman DW (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333:1600-1607
27. Laporte JR, Carné X, Vidal X, Moreno V, Juan J , The Catalan Countries Study on Upper Gastrointestinal Bleeding (1991) Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 337:85-89
28. Andrade SE, Martínez C, Walker AM (1998) Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol 51:1357-1365